Insertion of foreign epitopes in HBcAg: How to make the chimeric particle assemble

Amino Acids

Volumn 18, Issue 4, 2000, Pages 329-337

  Karpenko, Larissa I ^a   Ivanisenko, V A ^a   Pika, I A ^a   Chikaev, N A ^b   Eroshkin, A M ^a   Veremeiko, T A ^a   Ilyichev, A A ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Amino acids HBcAg; Core particles; Foreign epitopes; Self assemble

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; HEPATITIS B CORE ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0033947259     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260070072     Document Type: Article

References (26)

1. Argos P, Fuller SD (1988) A model for the hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J 7: 819-824
2. Bogardt RA, Jones BN, Durilet FE, Garher WH, Lehman LD, Gurd FRN (1980) Evolution of the amino acid substitution in the mammalian myoglobin gene. J Mol Evol 15: 197-218
3. Borisova G, Arya B, Dislers A, Borschukova O, Tsibinogin V, Skrastina D, Eldarov MA, Pumpens P, Skryabin KG, Grens E (1993) Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen. J Virol 67: 3696-3701
4. Boulter NR, Glass EJ, Knight PA, Bell-Sakyi L, Brown CGD, Hall R (1995) Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial. Vaccine 13: 1152-1160
5. Chou PY, Fasman GD (1978) Prediction of secondary structure of proteins from their amino acid sequence. Adv Enzymol 47: 145-147
6. Clarke BE, Newton S, Carrol AR, Francis MJ, Appleyard G, Syred A, Highfield PE, Rowlands DJ, Brown F (1987) Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330: 381-384
7. Clarke BE, Carrol AR, Brown AL, Jon J, Parry NR, Rud EW, Francis MJ, Rowlands DJ (1991) Expression and immunological analysis of hepatitis-B core fusion particles carrying internal heterologous sequences. In: Brown F, Chanock RM, Ginsberg HS, Lerner RA (eds) Vaccines '91. Cold Spring Harbor Laboratory Press, New York, pp 313-318
8. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpen P (1994) Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77: 943-950
9. Eroshkin AM, Fomin VI, Zhilkin PA, Ivanisenko VV, Kondakhin YV (1995) Proanal version 2: multifunctional program for analysis of multiple protein sequence alignments and for stutying the structure-activity relationship in protein families. CABIOS 11:39-44
10. Gren E, Pumpen P (1988) Recombinant viral capsids: new generation of immunogenic proteins and vaccines. Zhurnal Vsesojuznogo Khimicheskogo Obschestva Im Mendeleeva (Moscow) 33: 531-536
11. Ivanisenko VA (1998) Computer analysis of activity and properties relationship in families of similar and mutant proteins. Dissertation, Institute of Molecular Biology, Novosibirsk, Russia, p 35
12. Karpenko LI (1993) Directed reconstruction of hepatitis B core protein (HBcAg). Dissertation, Institute of Molecular Biology, Novosibirsk, Russia, p 70
13. Karpenko LI, Ilyichev AA (1998) Chimeric hepatitis B core particles as a presentation system of epitopes of foreign proteins. Vestnik Rus Akadem Nauk (Moskow) 6: 6-9
14. Loktev VB, Ilychev AA, Eroshkin AM, Karpenko LI, Pokrovsky AG, Pereboev AV, Svyatchenko VA, Ignat'ev GM, Smolina MI, Melamed NV, Lebedeva CD, Sandakhchiev LS (1996) Design of immunogenes as component of a new generation of molecular vaccines. J Biotech 44: 129-137
15. Lomonosoff GP, Johnson JE (1995) Viral expression systems for peptides. Seminars in Virology 6: 257-267
16. Makeeva IV, Kalinina TI, Khudyakov YuE, Samoshin VV, Smirnova EA, Semiletov YuA, Pavlyuchenkova RP, Kadoshnikov YuP, Smirnov VD (1995) Heterologous epitope in the central region of hepatitis B virus core protein. Molekul Biologiya (Moscow) 29: 125-131
17. Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis b virus is both T-cell independent and T-cell dependent antigen. Science 234: 1398-1401
18. Nassal M (1988) Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization. Gene 66: 279-294
19. Pumpens P, Borisova GP, Crowther RA, Grens E (1995) Hepatitis B virus core particles as epitope carriers. Intervirol 38: 63-74
20. Rost B, Sander C (1994) Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19: 55-72
21. Schodel F, Thomas W, Will H, Milich D (1990) Recombinant HBV core particles carrying immunodominant B-cell epitopes of the HBV Pre-S2 region. Vaccines '90. Cold Spring Harbor Laboratory Press, Cold Spring Harbor New York, pp 193-198
22. Schodel F, Will H, Milich D (1991) Hybrid hepatitis B virus core/pre-S particles expressed in live attenuated Salmonella for oral immunization. In: Chanock RM, Ginsberg HS, Brown F, Lerner RA (eds) Vaccines '91. Cold Spring Harbor Laboratory Press, New York, pp 319-325
23. Schodel F, Kelly S, Tinge S, Hopkins S, Peterson D, Milich D and Curtiss III R (1996) Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. In: Cohen S, Shafferman A (eds) Novel strategies in design and production of vaccines. Plenum Press, New York, pp 15-21
24. Tindle RW, Herd K, Londono P, Fernando GJP, Chatfield SN, Malcolm K, Dougan G (1994) Chimeric hepatitis B core antigen particles containing B-and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice. Virology 200: 547-557
25. Ulrich R, Nassal M, Meisel H, Kruger DH (1998) Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res 50: 141-182
26. Von Brunn A, Brand M, Reichhuber C, Morys-Wortmann C, Deinhardt F, Schodel F (1993) Principal neutralising domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles. Vaccine 11: 817-824